Vascular Endothelial Growth Factor and Other Signaling Pathways in Developmental and Pathologic Angiogenesis
- 1 July 2004
- journal article
- review article
- Published by Springer Nature in International Journal of Hematology
- Vol. 80 (1) , 7-20
Abstract
The field of angiogenesis received a huge boost in 2003 with the announcement of positive results in a phase III clinical trial using a vascular endothelial growth factor (VEGF)-blocking antibody for...Keywords
This publication has 154 references indexed in Scilit:
- Molecular regulation of vessel maturationNature Medicine, 2003
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Mouse gridlockCurrent Biology, 2002
- ‘Accidental’ anti-angiogenic drugsEuropean Journal of Cancer, 2000
- Notch Signaling: Cell Fate Control and Signal Integration in DevelopmentScience, 1999
- Efficacy and Concentration-Response of Murine Anti-VEGF Monoclonal Antibody in Tumor-Bearing Mice and Extrapolation to HumansToxicologic Pathology, 1999
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971